Cargando…
First trimester diagnosis and screening for fetal aneuploidy
Maternal serum screening for neural tube defects and fetal aneuploidy in the second trimester has been incorporated into obstetrical practice over the past two decades. Now, as a result of several multicenter trials, first trimester screening between 11 and 14 weeks has been shown to be an effective...
Autores principales: | Driscoll, Deborah A., Gross, Susan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott, Williams & Wilkins
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110997/ https://www.ncbi.nlm.nih.gov/pubmed/18197059 http://dx.doi.org/10.1097/GIM.0b013e31815efde8 |
Ejemplares similares
-
Screening for fetal aneuploidy and neural tube defects
por: Driscoll, Deborah A., et al.
Publicado: (2009) -
Carrier screening in individuals of Ashkenazi Jewish descent
por: Gross, Susan J., et al.
Publicado: (2008) -
Indications for genetic referral: a guide for healthcare providers
por: Pletcher, Beth A., et al.
Publicado: (2007) -
Fragile X syndrome: Diagnostic and carrier testing
por: Sherman, Stephanie, et al.
Publicado: (2005) -
Pompe disease diagnosis and management guideline
por: Kishnani, Priya S., et al.
Publicado: (2006)